IPSEN BIOPHARM LIMITED (01653765) is a private limited company registered in WREXHAM, incorporated in 1982. The company operates in the manufacture of basic pharmaceutical products sector. With 104 data signals collected from 16 government and public sources, IPSEN BIOPHARM LIMITED has one of the more comprehensive data profiles in our database. The current risk score is 72/100, classified as "stable". Note: the company's accounts appear to be overdue.
Ipsen Biopharm Limited (01653765) is an active private limited company incorporated in 1982, situated in Wrexham, involved in the manufacture of basic
Extensive data coverage from 16 government and public sources. Risk score of 72 — no major risk signals detected.
IPSEN BIOPHARM LIMITED is 1 of 4 manufacture of basic pharmaceutical products companies in WREXHAM, out of 1,064 active companies in this sector nationally (1,330 including dissolved).
IPSEN BIOPHARM LIMITED is listed as the proprietor of 7 properties in the HM Land Registry.
Properties are located in South East, Wales.
IPSEN BIOPHARM LIMITED has received 1 Innovate UK grant.
IPSEN BIOPHARM LIMITED pays invoices in an average of 31 days. 61% are paid within 30 days.
IPSEN BIOPHARM LIMITED has been mentioned in 2 London or Edinburgh Gazette notices.
Gazette notices are official public records that may relate to company changes, winding-up petitions, or other statutory notifications.
This company profile is built from 14 official data sources: Ch Officers, Companies House, Environment Agency, GLEIF, Gateway to Research, Gender Pay Gap Service, HM Land Registry, HMRC Trade Info, ICO, Innovate UK, Modern Slavery Registry, Payment Practices, The Gazette, Uk Trade Info.
Ipsen Biopharm Limited (01653765) is an active private limited company incorporated in 1982, situated in Wrexham, involved in the manufacture of basic.
Current directors include DR JOHN ANDREW CHADDOCK, , and 2 more.
IPSEN BIOPHARM LIMITED is registered in WREXHAM, United Kingdom.
IPSEN BIOPHARM LIMITED operates under SIC code 21100 — Manufacture of basic pharmaceutical products.
IPSEN BIOPHARM LIMITED has a risk score of 72 out of 100, classified as "Stable". This score is calculated from 104 data signals across 16 government sources.
The next accounts for IPSEN BIOPHARM LIMITED are due on 30 Sept 2026 — this filing is currently overdue.
Yes, IPSEN BIOPHARM LIMITED is listed as the proprietor of 7 properties in the HM Land Registry, located in South East, Wales.
The dissolution rate for the manufacture of basic pharmaceutical products sector in the UK is 12%. The average company age in this sector is 14.8 years.
IPSEN BIOPHARM LIMITED is currently listed as "Active" on Companies House, indicating it is still a registered company. An "Active" status means the company has not been dissolved, struck off, or entered into liquidation.
IPSEN BIOPHARM LIMITED is registered as a Private Limited Company, which is a company limited by shares whose shares are not offered to the general public. It is the most common type of UK company, offering limited liability to its shareholders.
IPSEN BIOPHARM LIMITED was incorporated on 23 Jul 1982, making it 44 years old. The company remains active and in good standing.
IPSEN BIOPHARM LIMITED is classified under SIC code 21100 (Manufacture of basic pharmaceutical products). The Standard Industrial Classification system is used by the UK government to categorise businesses by their primary economic activity.
We track 104 data signals from 16 official government sources for IPSEN BIOPHARM LIMITED.